A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
Phase 4
Completed
- Conditions
- Moderate to Severe Dry Eye
- Interventions
- Other: Systane
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 300
- Registration Number
- NCT01311609
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1184
- Registration Number
- NCT01309204
ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients
Phase 1
Completed
- Conditions
- Exudative Age-Related Macular Degeneration
- Interventions
- Biological: Ranibizumab 0.5 mgBiological: ESBA1008 solution
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 376
- Registration Number
- NCT01304693
A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: ReSTOR +3Device: LENTIS MPlus
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT01299155
- Locations
- 🇪🇸
Contact Alcon Call Center for Trial Locations, Oviedo, Asturias, Spain
Divided Dose of TRAVATAN®
Phase 2
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2017-05-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 67
- Registration Number
- NCT01298687
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2013-07-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1062
- Registration Number
- NCT01297920
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1001
- Registration Number
- NCT01297517
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Lubricant Eye DropOther: Refresh Liquigel
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 147
- Registration Number
- NCT01294956
Patient Perception Study for AL-4943A
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 47
- Registration Number
- NCT01294969
- Locations
- 🇰🇷
Alcon Korea Ltd., Seoul, Korea, Republic of
Visual Outcomes After Cataract Surgery: Multifocal AcrySof® IQ ReSTOR® Intraocular Lenses Versus Monofocal Intraocular Lenses
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOLDevice: Monofocal IOLDevice: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 208
- Registration Number
- NCT01290068
© Copyright 2025. All Rights Reserved by MedPath